Emdin Abby, Strzelecki Marina, Seto Winnie, Feinstein James, Bogler Orly, Cohen Eyal, Roth Daniel E
Child Health Evaluative Sciences and SickKids Research Institute, The Hospital for Sick Children, Toronto, Ontario, Canada.
Dalla Lana School of Public Health.
Hosp Pediatr. 2021 Dec 1. doi: 10.1542/hpeds.2021-006080.
Discharge prescription practices may contribute to medication overuse and polypharmacy. We aimed to estimate changes in the number and types of medications reported at inpatient discharge (versus admission) at a tertiary care pediatric hospital.
Electronic medication reconciliation data were extracted for inpatient admissions at The Hospital for Sick Children from January 1, 2016, to December 31, 2017 (n = 22 058). Relative changes in the number of medications and relative risks (RRs) of specific types and subclasses of medications at discharge (versus admission) were estimated overall and stratified by the following: sex, age group, diagnosis of a complex chronic condition, surgery, or ICU (PICU) admission. Micronutrient supplements, nonopioid analgesics, cathartics, laxatives, and antibiotics were excluded in primary analyses.
Medication counts at discharge were 1.27-fold (95% confidence interval [CI]: 1.25-1.29) greater than admission. The change in medications at discharge (versus admission) was increased by younger age, absence of a complex chronic condition, surgery, PICU admission, and discharge from a surgical service. The most common drug subclasses at discharge were opioids (22% of discharges), proton pump inhibitors (18%), bronchodilators (10%), antiemetics (9%), and corticosteroids (9%). Postsurgical patients had higher RRs of opioid prescriptions at discharge (versus admission; RR: 13.3 [95% CI: 11.5-15.3]) compared with nonsurgical patients (RR: 2.38 [95% CI: 2.22-2.56]).
Pediatric inpatients were discharged from the hospital with more medications than admission, frequently with drugs that may be discretionary rather than essential. The high frequency of opioid prescriptions in postsurgical patients is a priority target for educational and clinical decision support interventions.
出院处方行为可能导致药物过度使用和多重用药。我们旨在评估一家三级儿科医院住院患者出院时(与入院时相比)报告的药物数量和种类的变化。
提取了2016年1月1日至2017年12月31日期间在病童医院住院的电子药物核对数据(n = 22058)。总体上以及按以下因素分层估计了出院时(与入院时相比)药物数量的相对变化以及特定类型和亚类药物的相对风险(RRs):性别、年龄组、复杂慢性病诊断、手术或重症监护病房(PICU)入院情况。在主要分析中排除了微量营养素补充剂、非阿片类镇痛药、泻药、缓泻剂和抗生素。
出院时的药物数量是入院时的1.27倍(95%置信区间[CI]:1.25 - 1.29)。出院时(与入院时相比)药物的变化在年龄较小、无复杂慢性病、进行手术、入住PICU以及从外科病房出院的患者中更为明显。出院时最常见的药物亚类是阿片类药物(占出院患者的22%)、质子泵抑制剂(18%)、支气管扩张剂(10%)、止吐药(9%)和皮质类固醇(9%)。与非手术患者相比,手术后患者出院时阿片类药物处方的RRs更高(与入院时相比;RR:13.3[95%CI:11.5 - 15.3]),而非手术患者的RR为2.38[95%CI:2.22 - 2.56]。
儿科住院患者出院时携带的药物比入院时更多,且经常使用的药物可能并非必需而是可酌情使用的。手术后患者阿片类药物处方的高频率是教育和临床决策支持干预的重点目标。